Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer Assay for Measurement of Phox/Bem1p (PB1) Domain Heterodimerization

Abstract

Twenty human proteins encode Phox/Bem1p (PB1) domains, which are involved in forming protein heterodimers. MEKK2, MEKK3, and MEK5 are 3 serine-threonine protein kinases that have PB1 domains. MEKK2, MEKK3, and MEK5 are the MAP3Ks and the MAP2K in the ERK5 mitogen-activated protein kinase (MAPK) signaling module. ERK5 is a critical MAPK for both development of the vasculature and vascular homeostasis in the adult, but no other MAPK has been shown to be critical in vascular maintenance in the adult animal. MEKK2 and MEKK3 are the only MAP3Ks shown to physically interact with and activate the MEK5-ERK5 signaling module. Interaction of MEKK2 or MEKK3 with MEK5 is mediated by heterodimerization of the MEKK2 (or MEKK3) PB1 and MEK5 PB1 domains. The authors have developed a homogeneous, time-resolved fluorescence resonance energy transfer (TR-FRET) assay to monitor PB1-PB1 domain heterodimerization. The assay uses a europium-chelate conjugated GST-MEK5 PB1 domain chimera, biotinylated MEKK2 PB1 domain, and streptavidin-Cy5. Interaction of the MEKK2 and MEK5 PB1 domains gives a robust FRET signal (Z′ factor = 0.93), which is completely abrogated by mutation of 2 acidic residues (⁶⁴D⁶⁵E→AA) within the MEK5 PB1 domain that causes loss of stable PB1-PB1 domain interaction. This assay can be used to study the specificity of PB1-PB1 domain interactions and to screen for molecules that can regulate MEKK2/MEKK3-MEK5 interactions. Disruption of PB1 domain interactions represents a novel approach for selectively regulating the ERK5 signaling pathway independent of kinase active site-directed adenosine triphosphate competitive inhibitors. (Journal of Biomolecular Screening 2008:396-405)

Keywords

PB1 domain MEK5 MEKK2 TR-FRET assay

References

Sun W. , Wei X. , Kesavan K. , Garrington TP , Fan R. , Mei J. , et al: MEK kinase 2 and the adaptor protein Lad regulate extracellular signal-regulated kinase 5 activation by epidermal growth factor via Src. Mol Cell Biol 2003; 23:2298-2308.

Lee JD , Ulevitch RJ , Han J. : Primary structure of BMK1: a new mammalian map kinase. Biochem Biophys Res Commun 1995;213:715-724.

Cameron SJ , Malik S. , Akaike M. , Lerner-Marmarosh N. , Yan C. , Lee JD , et al: Regulation of epidermal growth factor-induced connexin 43 gap junction communication by big mitogen-activated protein kinase1/ERK5 but not ERK1/2 kinase activation. J Biol Chem 2003 ;278:18682-18688.

Pearson G. , English JM , White MA , Cobb MH : ERK5 and ERK2 cooperate to regulate NF-kappaB and cell transformation . J Biol Chem 2001;276:7927-7931.

Hayashi M. , Tapping RI , Chao TH , Lo JF , King CC , Yang Y. , et al: BMK1 mediates growth factor-induced cell proliferation through direct cellular activation of serum and glucocorticoid-inducible kinase. J Biol Chem 2001;276:8631-8634.

Kato Y. , Kravchenko VV , Tapping RI , Han J. , Ulevitch RJ , Lee JD : BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C. Embo J 1997;16:7054-7066.

Kamakura S. , Moriguchi T. , Nishida E. : Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases: identification and characterization of a signaling pathway to the nucleus . J Biol Chem 1999;274:26563-26571.

Akaike M. , Che W. , Marmarosh NL , Ohta S. , Osawa M. , Ding B. , et al: The hinge-helix 1 region of peroxisome proliferator-activated receptor gamma1 (PPARgamma1) mediates interaction with extracellular signal-regulated kinase 5 and PPARgamma1 transcriptional activation: involvement in flow-induced PPARgamma activation in endothelial cells. Mol Cell Biol 2004;24:8691-8704.

Kesavan K. , Lobel-Rice K. , Sun W. , Lapadat R. , Webb S. , Johnson GL , et al: MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts. J Cell Physiol 2004;199:140-148.

10.

Hayashi M. , Kim SW , Imanaka-Yoshida K. , Yoshida T. , Abel ED , Eliceiri B. , et al: Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J Clin Invest 2004;113:1138-1148.

11.

Hayashi M. , Fearns C. , Eliceiri B. , Yang Y. , Lee JD : Big mitogen-activated protein kinase 1/extracellular signal-regulated kinase 5 signaling pathway is essential for tumor-associated angiogenesis . Cancer Res 2005;65:7699-7706.

12.

Nakamura K. , Uhlik MT , Johnson NL , Hahn KM , Johnson GL : PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation. Mol Cell Biol 2006;26:2065-2079.

13.

Wilson MI , Gill DJ , Perisic O. , Quinn MT , Williams RL : PB1 domain-mediated heterodimerization in NADPH oxidase and signaling complexes of atypical protein kinase C with Par6 and p62. Mol Cell 2003; 12:39-50.

14.

Moscat J. , Diaz-Meco MT , Albert A. , Campuzano S. : Cell signaling and function organized by PB1 domain interactions. Mol Cell 2006;23:631-640.

15.

Sumimoto H. , Kamakura S. , Ito T. : Structure and function of the PB1 domain, a protein interaction module conserved in animals, fungi, amoebas, and plants. Sci STKE 2007;2007:re6.

16.

Nakamura K. , Johnson GL : PB1 domains of MEKK2 and MEKK3 interact with the MEK5 PB1 domain for activation of the ERK5 pathway. J Biol Chem 2003;278:36989-36992.

17.

Nakamura K. , Johnson GL : Noncanonical function of MEKK2 and MEK5 PB1 domains for coordinated extracellular signal-regulated kinase 5 and c-Jun N-terminal kinase signaling . Mol Cell Biol 2007;27:4566-4577.

18.

Toutchkine A. , Nguyen DV , Hahn KM : Simple one-pot preparation of water-soluble, cysteine-reactive cyanine and merocyanine dyes for biological imaging. Bioconjug Chem 2007;18:1344-1348.

19.

Getz EB , Xiao M. , Chakrabarty T. , Cooke R. , Selvin PR : A comparison between the sulfhydryl reductants tris(2-carboxyethyl)phosphine and dithiothreitol for use in protein biochemistry. Anal Biochem 1999;273:73-80.

20.

Hu Q. , Shen W. , Huang H. , Liu J. , Zhang J. , Huang X. , et al: Insight into the binding properties of MEKK3 PB1 to MEK5 PB1 from its solution structure. Biochemistry 2007;46:13478-13489.

21.

Arkin MR , Wells JA : Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 2004 ;3:301-317.

22.

Walters WP , Namchuk M. : Designing screens: how to make your hits a hit. Nat Rev Drug Discov 2003;2:259-266.

23.

Feng BY , Simeonov A. , Jadhav A. , Babaoglu K. , Inglese J. , Shoichet BK , et al: A high-throughput screen for aggregation-based inhibition in a large compound library. J Med Chem 2007;50:2385-2390.

24.

Leifert WR , Bailey K. , Cooper TH , Aloia AL , Glatz RV , McMurchie EJ : Measurement of heterotrimeric G-protein and regulators of G-protein signaling interactions by time-resolved fluorescence resonance energy transfer . Anal Biochem 2006;355:201-212.

25.

Wang X. , Tournier C. : Regulation of cellular functions by the ERK5 signalling pathway. Cell Signal 2006;18:753-760.

26.

Hirano Y. , Yoshinaga S. , Takeya R. , Suzuki NN , Horiuchi M. , Kohjima M. , et al: Structure of a cell polarity regulator, a complex between atypical PKC and Par6 PB1 domains. J Biol Chem 2005 ;280:9653-9661.

27.

Suzuki A. , Ohno S. : The PAR-aPKC system: lessons in polarity. J Cell Sci 2006;119:979-987.